3.33
price down icon1.19%   -0.04
after-market After Hours: 3.33
loading
Exagen Inc stock is traded at $3.33, with a volume of 274.92K. It is down -1.19% in the last 24 hours and down -22.92% over the past month. Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
See More
Previous Close:
$3.37
Open:
$3.42
24h Volume:
274.92K
Relative Volume:
1.67
Market Cap:
$58.73M
Revenue:
$52.55M
Net Income/Loss:
$-23.69M
P/E Ratio:
-3.5426
EPS:
-0.94
Net Cash Flow:
$-15.29M
1W Performance:
+4.39%
1M Performance:
-22.92%
6M Performance:
+10.63%
1Y Performance:
+83.98%
1-Day Range:
Value
$3.22
$4.10
1-Week Range:
Value
$2.77
$4.10
52-Week Range:
Value
$1.3003
$6.22

Exagen Inc Stock (XGN) Company Profile

Name
Name
Exagen Inc
Name
Phone
(760) 560-1501
Name
Address
1261 LIBERTY WAY, VISTA, CA
Name
Employee
179
Name
Twitter
@ExagenInc
Name
Next Earnings Date
2025-03-11
Name
Latest SEC Filings
Name
XGN's Discussions on Twitter

Compare XGN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
XGN
Exagen Inc
3.33 58.73M 52.55M -23.69M -15.29M -0.94
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
512.65 193.40B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
204.96 146.49B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
A
Agilent Technologies Inc
119.85 34.19B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
412.40 33.54B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
185.42 32.69B 15.41B 1.37B 2.11B 7.50

Exagen Inc Stock (XGN) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-05-22 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Oct-15-21 Resumed Cowen Outperform
Apr-15-21 Initiated Canaccord Genuity Buy
Nov-10-20 Initiated KeyBanc Capital Markets Overweight
Oct-08-20 Initiated BTIG Research Buy
Jun-02-20 Resumed Cantor Fitzgerald Overweight
Oct-14-19 Initiated Cantor Fitzgerald Overweight
Oct-14-19 Initiated Cowen Outperform
Oct-14-19 Initiated William Blair Outperform
View All

Exagen Inc Stock (XGN) Latest News

pulisher
08:09 AM

Exagen Inc. (NASDAQ:XGN) Q4 2024 Earnings Call Transcript - Insider Monkey

08:09 AM
pulisher
06:31 AM

Exagen Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance

06:31 AM
pulisher
06:20 AM

Exagen’s Positive Outlook: Buy Rating Backed by Strong Performance and Growth Potential - TipRanks

06:20 AM
pulisher
03:04 AM

Exagen Inc (XGN) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives - Yahoo Finance

03:04 AM
pulisher
12:11 PM

Exagen Inc. Reports Record 2024 Financial Results - TipRanks

12:11 PM
pulisher
Mar 11, 2025

BTIG maintains Buy rating, $5 target on Exagen stock By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

Earnings call transcript: Exagen Inc Q4 2024 sees revenue growth and stock rise - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Exagen posts smaller-than-expected fourth-quarter net loss -March 11, 2025 at 09:39 am EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Exagen Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

EXAGEN INC. SEC 10-K Report - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 11, 2025
pulisher
Mar 11, 2025

EXAGEN DIAGNOSTICS Earnings Results: $XGN Reports Quarterly Earnings - Nasdaq

Mar 11, 2025
pulisher
Mar 11, 2025

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights - The Manila Times

Mar 11, 2025
pulisher
Mar 11, 2025

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results - TradingView

Mar 11, 2025
pulisher
Mar 09, 2025

EXAGEN DIAGNOSTICS Earnings Preview: Recent $XGN Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 09, 2025
pulisher
Mar 09, 2025

Exagen (XGN) Expected to Announce Earnings on Tuesday - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

Exagen Inc. (NASDAQ:XGN) Short Interest Update - Defense World

Mar 07, 2025
pulisher
Mar 04, 2025

Is Exagen (NASDAQ:XGN) Using Debt In A Risky Way? - Simply Wall St

Mar 04, 2025
pulisher
Mar 02, 2025

Investors in Exagen (NASDAQ:XGN) have unfortunately lost 84% over the last five years - Yahoo Finance

Mar 02, 2025
pulisher
Feb 25, 2025

Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025 - GlobeNewswire

Feb 25, 2025
pulisher
Feb 25, 2025

When Will Exagen Report Q4 Earnings? Key Date for Autoimmune Testing Investors - StockTitan

Feb 25, 2025
pulisher
Feb 18, 2025

Stocks Surge Across Health Services and Industry Sectors: Nuvve, Exagen, and Flexsteel Lead the Way - HPBL

Feb 18, 2025
pulisher
Feb 17, 2025

What Do Wall Street Analysts Think About Exagen Inc (NASDAQ: XGN) Stock? - Stocks Register

Feb 17, 2025
pulisher
Feb 17, 2025

Exagen Inc. (NASDAQ:XGN) Short Interest Up 260.8% in January - MarketBeat

Feb 17, 2025
pulisher
Feb 14, 2025

Volcon, Flexsteel, Palantir and More See Stock Surge After Positive Earnings and Strategic Deals - HPBL

Feb 14, 2025

Exagen Inc Stock (XGN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$144.50
price up icon 3.20%
diagnostics_research DGX
$166.42
price down icon 1.03%
diagnostics_research LH
$236.83
price down icon 1.01%
diagnostics_research WAT
$373.13
price down icon 1.51%
diagnostics_research MTD
$1,216.02
price down icon 2.18%
diagnostics_research IQV
$185.42
price up icon 1.06%
Cap:     |  Volume (24h):